Browse by author
Lookup NU author(s): Hanna Salmonowicz, Dr James ChapmanORCiD, George Kelly, Professor Laura GreavesORCiD, Professor Derek Mann, Professor Viktor KorolchukORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2023, The Author(s). Senescent cells drive age-related tissue dysfunction partially through the induction of a chronic senescence-associated secretory phenotype (SASP)1. Mitochondria are major regulators of the SASP; however, the underlying mechanisms have not been elucidated2. Mitochondria are often essential for apoptosis, a cell fate distinct from cellular senescence. During apoptosis, widespread mitochondrial outer membrane permeabilization (MOMP) commits a cell to die3. Here we find that MOMP occurring in a subset of mitochondria is a feature of cellular senescence. This process, called minority MOMP (miMOMP), requires BAX and BAK macropores enabling the release of mitochondrial DNA (mtDNA) into the cytosol. Cytosolic mtDNA in turn activates the cGAS–STING pathway, a major regulator of the SASP. We find that inhibition of MOMP in vivo decreases inflammatory markers and improves healthspan in aged mice. Our results reveal that apoptosis and senescence are regulated by similar mitochondria-dependent mechanisms and that sublethal mitochondrial apoptotic stress is a major driver of the SASP. We provide proof-of-concept that inhibition of miMOMP-induced inflammation may be a therapeutic route to improve healthspan.
Author(s): Victorelli S, Salmonowicz H, Chapman J, Martini H, Vizioli MG, Riley JS, Cloix C, Hall-Younger E, Machado Espindola-Netto J, Jurk D, Lagnado AB, Sales Gomez L, Farr JN, Saul D, Reed R, Kelly G, Eppard M, Greaves LC, Dou Z, Pirius N, Szczepanowska K, Porritt RA, Huang H, Huang TY, Mann DA, Masuda CA, Khosla S, Dai H, Kaufmann SH, Zacharioudakis E, Gavathiotis E, LeBrasseur NK, Lei X, Sainz AG, Korolchuk VI, Adams PD, Shadel GS, Tait SWG, Passos JF
Publication type: Article
Publication status: Published
Journal: Nature
Year: 2023
Volume: 622
Pages: 627-636
Print publication date: 19/10/2023
Online publication date: 11/10/2023
Acceptance date: 07/09/2023
Date deposited: 17/01/2024
ISSN (print): 0028-0836
ISSN (electronic): 1476-4687
Publisher: Springer Nature
URL: https://doi.org/10.1038/s41586-023-06621-4
DOI: 10.1038/s41586-023-06621-4
Data Access Statement: The RNA-seq datasets generated and analysed during this study are available at the Gene Expression Omnibus (GSE196610 and GSE235225). The MS proteomics data have been deposited at the ProteomeXchange Consortium through the PRIDE partner repository under dataset identifier PXD040018. Source data are provided with this paper.
PubMed id: 37821702
Altmetrics provided by Altmetric
